What one share of Lexicon Pharmaceuticals holds
We are a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. We are devoting most of our resources to the research and development of our most advanced drug candidates and the commercialization of our approved drug, INPEFA® (sotagliflozin):
Lexicon Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.11 |
|---|---|
| Profit | −$0.16 |
| Cash and investments | $0.09 |
| Debt | $0.12 |
| Book value | $0.39 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | — | −$3.99 | $0.02 | −$4.31 | — | $7.88 |
| 2010 | — | −$2.35 | $0.03 | −$1.93 | — | $5.71 |
| 2011 | — | −$2.39 | $0.02 | −$1.83 | — | $4.33 |
| 2012 | — | −$1.58 | $0.01 | −$1.36 | — | $3.64 |
| 2013 | — | −$1.42 | $0.02 | −$1.27 | — | $2.32 |
| 2014 | — | −$1.31 | $0.00 | −$0.99 | — | $2.74 |
| 2015 | — | −$0.05 | $0.01 | $1.77 | — | $2.76 |
| 2016 | — | −$1.27 | $0.00 | −$1.69 | — | $1.61 |
| 2017 | — | −$1.17 | $0.00 | −$1.76 | — | $0.65 |
| 2018 | — | −$1.14 | $0.00 | −$1.41 | — | −$0.25 |
| 2019 | — | $1.16 | $0.00 | $0.97 | — | $0.81 |
| 2020 | — | −$0.53 | $0.00 | −$1.29 | — | $1.11 |
| 2021 | $0.00 | −$0.60 | $0.01 | −$0.61 | — | $0.76 |
| 2022 | $0.00 | −$0.62 | $0.01 | −$0.54 | — | $0.62 |
| 2023 | $0.01 | −$0.80 | $0.00 | −$0.73 | — | $0.38 |
| 2024 | $0.10 | −$0.63 | $0.00 | −$0.56 | — | $0.40 |
| 2025 | $0.14 | −$0.14 | $0.00 | −$0.19 | — | $0.29 |
Common questions about Lexicon Pharmaceuticals
How much does one share of Lexicon Pharmaceuticals earn?
Over the last 12 months, Lexicon Pharmaceuticals lost $0.16 for each share on $0.11 of sales.
Does Lexicon Pharmaceuticals pay a dividend?
Lexicon Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Lexicon Pharmaceuticals’s book value per share?
Lexicon Pharmaceuticals’s book value is $0.39 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Lexicon Pharmaceuticals have?
Each share of Lexicon Pharmaceuticals has $0.09 of cash and investments and $0.12 of debt, as of June 30, 2026.
Has Lexicon Pharmaceuticals bought back shares?
Lexicon Pharmaceuticals’s share count rose about 1650% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.